- Home
- WAFU vs MBRX Comparison
WAFU vs MBRX Comparison
Compare WAFU & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- MBRX
- Stock Information
- Founded
- WAFU 1999
- MBRX 2015
- Country
- WAFU China
- MBRX United States
- Employees
- WAFU N/A
- MBRX N/A
- Industry
- WAFU Other Consumer Services
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- MBRX Health Care
- Exchange
- WAFU Nasdaq
- MBRX Nasdaq
- Market Cap
- WAFU 7.1M
- MBRX 7.0M
- IPO Year
- WAFU 2019
- MBRX 2016
- Fundamental
- Price
- WAFU $1.47
- MBRX $1.85
- Analyst Decision
- WAFU
- MBRX Strong Buy
- Analyst Count
- WAFU 0
- MBRX 3
- Target Price
- WAFU N/A
- MBRX $31.00
- AVG Volume (30 Days)
- WAFU 21.8K
- MBRX 47.1K
- Earning Date
- WAFU 01-01-0001
- MBRX 11-08-2024
- Dividend Yield
- WAFU N/A
- MBRX N/A
- EPS Growth
- WAFU N/A
- MBRX N/A
- EPS
- WAFU N/A
- MBRX N/A
- Revenue
- WAFU $7,223,220.00
- MBRX N/A
- Revenue This Year
- WAFU N/A
- MBRX N/A
- Revenue Next Year
- WAFU N/A
- MBRX N/A
- P/E Ratio
- WAFU N/A
- MBRX N/A
- Revenue Growth
- WAFU N/A
- MBRX N/A
- 52 Week Low
- WAFU $1.46
- MBRX $0.40
- 52 Week High
- WAFU $2.85
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- WAFU 33.27
- MBRX 34.90
- Support Level
- WAFU $1.46
- MBRX $1.81
- Resistance Level
- WAFU $1.59
- MBRX $3.10
- Average True Range (ATR)
- WAFU 0.10
- MBRX 0.25
- MACD
- WAFU -0.01
- MBRX -0.08
- Stochastic Oscillator
- WAFU 2.86
- MBRX 6.40
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.